Parkinson’s disease is a common neurodegenerative disease. Tit affects approximately 2% of the elderly people in the United States. Studies show that there is a clear difference for the onset of Parkinson’s disease in sex and race distribution. One of the emotional impacts of Parkinson disease among the males is mood disturbances which accounts for about 40% of the patients followed psychiatric illness which accounts for 57.7% (Willis, Schootman, Kung & Racette, 2013). The identification of Parkinson’s disease across gender and race has been limited by the difficulty in identifying a large number of affected individual in one area. There is low frequency of people with Parkinson disease. This article discusses that the incidence of Parkinson disease among the Hispanic people is the highest among the different races. The high incidence was reported for both the males and the females (Van Den Eeden, 2013).
People that have Parkinson disease have been known to suffer from degenerative nervous system disorder as explained by (Willis et al. 2013). Additionally, dementia has a high incidence among the males suffering from PD. Among men, Parkinson’s disease has been identified to affect the visuo-perceptual deficits and cause slowness or perceptual processing. PD leads to nervousness and a lack of confidence which affects driving skills of the patient (Crizzle, Myers & Almeida, 2012). According to Willis, Schootman, Evanoff, BPerlmutter & Racette, (2011), Parkinson disease is more common in whites than any other groups. This study is inconsistent with the one discussed above where it states Parkinson disease is common among the Hispanics. The authors however state that unknown medical and social factors may have influenced the study. The authors Callaghan, Cunningham, Sykes & Kish, (2012) discusses that the use of substance use such as meth has increased the incidence of PD. Such substance use can be attributed to emotional instability of some PD patient who probably used this substance.
- Callaghan, R. C., Cunningham, J. K., Sykes, J., & Kish, S. J. (2012). Increased risk of Parkinson’s disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug and alcohol dependence, 120(1), 35-40.
- Crizzle, A. M., Myers, A. M., & Almeida, Q. J. (2012). Drivers with parkinson’s disease: Who participates in research studies?. Parkinsonism & related disorders, 18(7), 833-836.
- Van Den Eeden, S. K., Tanner, C. M., Bernstein, A. L., Fross, R. D., Leimpeter, A., Bloch, D. A., & Nelson, L. M. (2003). Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. American journal of epidemiology, 157(11), 1015-1022.
- Willis, A. W., Schootman, M., Evanoff, B. A., Perlmutter, J. S., & Racette, B. A. (2011). Neurologist care in Parkinson disease A utilization, outcomes, and survival study. Neurology, 77(9), 851-857.
- Willis, A. W., Schootman, M., Kung, N., & Racette, B. A. (2013). Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson’s Disease in the United States. Parkinsonism & related disorders, 19(2), 202-206.
- Willis, A. W., Schootman, M., Kung, N., Evanoff, B. A., Perlmutter, J. S., & Racette, B. A. (2012). Predictors of survival in patients with Parkinson disease. Archives of neurology, 69(5), 601-607.